Iodine Supplements: What They Help, How Much to Take, and Safety

The NIH review summarizes the clearest practical evidence: iodine is essential for T4 and T3 production, common supplement forms include potassium iodide and sodium iodide, and higher-risk groups include pregnant women, people avoiding iodized salt, and some vegans. (NIH Office of Dietary Supplements — Iodine Fact Sheet)

In mildly deficient adults, 150 mcg per day for 24 weeks increased urinary iodine and lowered thyroglobulin, but it did not materially change TSH or free T4. The study supports correction of status more than broad thyroid enhancement. (PubMed — Iodine Supplementation of Mildly Iodine-Deficient Adults Lowers Thyroglobulin)

Pregnancy research shows a repeated pattern: supplementation around 150 to 300 mcg per day can improve iodine status and lower thyroglobulin, yet consistent improvements in maternal thyroid outcomes, neonatal markers, or child neurodevelopment have not been clearly demonstrated in mild deficiency. (PubMed — Systematic review on pregnancy supplementation and neurocognitive outcomes; PubMed — Swedish pregnancy iodine trial)

One trial found that either a daily 225 mcg iodine capsule or iodized salt improved maternal iodine-related measures over 26 weeks. However, it did not show a simple cognitive advantage for infants from one iodine strategy over the other. (PubMed — Trial in lactating women and infants)

Safety guidance from endocrine authorities warns that chronic high-dose iodine or kelp intake can provoke thyroid dysfunction, and clinical guidance notes iodine usually does not help ordinary hypothyroidism unless deficiency is the cause. A cyclic breast-pain trial also used a multi-ingredient formula, so it cannot prove iodine alone works. (American Thyroid Association — Statement on excess iodine risks; Mayo Clinic — Hypothyroidism and iodine FAQ; PubMed — Multicenter trial in cyclic breast pain)

The evidence does not support a “more is better” model. Iodine has a narrow adequacy range: deficiency is harmful, but excess can also trigger thyroid dysfunction, especially in susceptible people and with chronic use of kelp or concentrated iodine products. (NIH Office of Dietary Supplements — Iodine Fact Sheet; American Thyroid Association — Statement on excess iodine risks)

This is usually untrue in iodine-sufficient countries, where many cases of hypothyroidism are caused by autoimmune disease rather than simple iodine lack. Clinical guidance from Mayo Clinic states that iodine supplements generally do not help unless deficiency is the cause, and too much iodine may make hypothyroidism worse. (Mayo Clinic — Hypothyroidism and iodine FAQ)

Potassium iodide is evidence-based for a very specific emergency use: reducing thyroid uptake of radioactive iodine after qualifying exposure. It is not a general radioprotection supplement. Likewise, claims for high-dose iodine in breast symptoms or routine child-IQ improvement remain weak, and kelp products are especially unpredictable because iodine content can vary widely. (FDA — Potassium iodide emergency FAQ; PubMed — Multicenter trial in cyclic breast pain; PubMed — Systematic review on pregnancy supplementation and neurocognitive outcomes; NIH Office of Dietary Supplements — Iodine Fact Sheet)

Iodine stands out among supplements because its main importance is public-health prevention of deficiency rather than “optimization.” Historically, inadequate iodine intake caused endemic goiter and a wider group of iodine deficiency disorders, especially in inland or mountainous regions with iodine-poor soil. That history explains why iodized salt programs became central public-health tools and why WHO still treats salt iodization as the cornerstone strategy for prevention. In practice, iodine is best understood first as an essential nutrient and only second as a discretionary supplement. (WHO guidance on iodine deficiency monitoring; NIH Office of Dietary Supplements — Iodine Fact Sheet)

The mechanism is well established: iodine is required for synthesis of thyroid hormones T4 and T3. Those hormones influence metabolic rate throughout life and are especially important during fetal and infant development. This explains why deficiency can affect thyroid size, energy regulation, and developmental outcomes, but it does not imply that extra iodine improves health when intake is already adequate. (NCBI Bookshelf — Iodine in Health and Disease; EFSA Dietary Reference Values for Iodine)

Guidance consistently identifies pregnant and breastfeeding women, people who do not use iodized salt, those living in low-iodine food environments, and people avoiding seafood, dairy, and eggs as higher-risk groups for low intake. Strict vegan diets can also become a practical risk scenario unless fortified foods or supplements are used. Mild insufficiency can therefore exist even in high-income settings, but it does not affect all adults equally. (NIH Office of Dietary Supplements — Iodine Fact Sheet; NHS — Iodine overview)

In supplements, iodine is usually supplied as potassium iodide or sodium iodide, and many multivitamins provide about 150 mcg. Seaweed and kelp are natural iodine sources, but their content is highly variable, making them less predictable than standardized supplements. Practically, this means a labeled multivitamin or prenatal product is easier to dose safely than a kelp-based “thyroid support” supplement. (NIH Office of Dietary Supplements — Iodine Fact Sheet; American Thyroid Association — Statement on excess iodine risks; NHS — Iodine overview)

Iodine from iodide salts is generally well absorbed, so trials often focus on biomarkers such as urinary iodine concentration and thyroglobulin rather than on absorption alone. WHO uses urinary iodine heavily for population monitoring, and randomized research in mildly deficient adults shows a consistent pattern: 150 mcg per day can raise urinary iodine and lower thyroglobulin, indicating improved iodine status. That is a real and useful effect when intake is low. (WHO guidance on iodine deficiency monitoring; PubMed — Iodine Supplementation of Mildly Iodine-Deficient Adults Lowers Thyroglobulin)

What the same research does not show is a dramatic short-term thyroid benefit in otherwise healthy mildly deficient adults. In the 24-week randomized trial, TSH and free T4 changed little even though status markers improved. For consumers, that matters: supplementation is best viewed as correction of low intake rather than as a broad metabolic enhancer that predictably changes thyroid blood tests or boosts thyroid performance in everyone. (PubMed — Iodine Supplementation of Mildly Iodine-Deficient Adults Lowers Thyroglobulin)

Pregnancy and breastfeeding receive special attention because fetal and infant iodine supply depends on maternal intake. The American Thyroid Association recommends a daily supplement containing 150 mcg iodine, ideally as potassium iodide, for women planning pregnancy, pregnant, or breastfeeding, and preferably starting before conception. This recommendation reflects biological importance and the possibility that usual diet may not cover needs. (American Thyroid Association — Iodine supplementation in pregnancy and breastfeeding)

At the same time, the effectiveness literature is more nuanced than the recommendation itself. Trials and reviews usually show improved iodine biomarkers, but they do not consistently show clear gains in maternal thyroid outcomes, neonatal thyroid markers, or child neurocognitive outcomes in mildly deficient populations. Recent reviews also highlight a likely U-shaped relationship, suggesting both too little and too much iodine may be unfavorable during pregnancy and lactation. The practical takeaway is that adequacy matters, but more is not automatically better. (PubMed — Swedish pregnancy iodine trial; PubMed — Systematic review on pregnancy supplementation and neurocognitive outcomes; PubMed — Review on iodine in pregnancy, lactation, and cognition)

During lactation, iodine remains relevant because breast milk iodine reflects maternal supply. One randomized trial showed that either a daily iodine capsule or properly iodized salt improved maternal iodine-related measures over 26 weeks, including lower maternal TSH and lower goiter prevalence. This supports the practical idea that maintaining adequacy during breastfeeding is sensible and measurable. (PubMed — Trial in lactating women and infants; NIH Office of Dietary Supplements — Iodine Fact Sheet)

What the study did not establish was a simple cognitive advantage for infants from one iodine strategy over the other. More broadly, claims that iodine reliably improves cognition, optimizes thyroid function, or independently treats breast symptoms go beyond the evidence. Some breast-pain research used multi-ingredient formulas containing iodine along with selenium and gamma-linolenic acid, so iodine’s independent role was not isolated. The best-supported position remains prevention of deficiency, not routine enhancement claims. (PubMed — Trial in lactating women and infants; PubMed — Multicenter trial in cyclic breast pain; PubMed — Systematic review on pregnancy supplementation and neurocognitive outcomes)

The main safety issue is imbalance rather than deficiency alone. Excess iodine can trigger hypothyroidism, hyperthyroidism, thyroiditis, or worsening of pre-existing thyroid disease, with particular concern in infants, older adults, pregnancy, lactation, and people with autoimmune thyroid disease or thyroid autonomy. Kelp and seaweed products add practical risk because their iodine content can be highly variable, making real-world overdosing easier than with standardized supplements. (NIH Office of Dietary Supplements — Iodine Fact Sheet; American Thyroid Association — Statement on excess iodine risks)

A separate, evidence-based medical use exists for potassium iodide in radiation emergencies. FDA guidance confirms that KI can block thyroid uptake of radioactive iodine after qualifying exposure, but this is not a general radioprotection supplement role. Regulatory frameworks also differ: in the US, iodine is a lawful dietary ingredient and the Daily Value is 150 mcg; in the EU, EFSA recognizes essentiality and supports specific health claims, while upper-limit and risk-management approaches can be stricter, including lower proposed supplement maxima in Germany. (FDA — Potassium iodide emergency FAQ; FDA — Daily Value reference chart; EFSA — Scientific opinion on iodine health claims; BfR — Proposed maximum levels for iodine in supplements)